An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.
Conclusion & alert: CVE-2023-33364 is rated High Risk (65.3/100): CVSS High severity, with medium exploitation likelihood (EPSS 2.96%). Mandatory action: High exploitation likelihood—assess exposure and prioritize remediation.
Risk is dynamic; we continuously reassess and refresh what is shown on this page as upstream context changes.
EPSS lead: Daily EPSS estimates relative likelihood of exploitation; percentile ranks this CVE among scored vulnerabilities (higher = more severe relative rank).
| # | Date | Old EPSS score | New EPSS score | Delta (New - Old) |
|---|---|---|---|---|
| 1 | 2026-04-28 | 3.12% | 2.96% | -0.17% |
| 2 | 2026-03-04 | 2.41% | 3.12% | +0.71% |
| 3 | 2025-11-21 | — | 2.41% | — |
Full EPSS history (11 records total)
CVSS metrics for this CVE.
| Base score | Version | Severity | Vector | Exploitability | Impact | Score source |
|---|---|---|---|---|---|---|
| 8.8 | 3.1 | HIGH |
|
2.8 | 5.9 | [email protected] |
| Vendor | Product | Version | Raw CPE |
|---|---|---|---|
| supremainc | biostar_2 | < 2.9.1 | cpe:2.3:a:supremainc:biostar_2:*:*:*:*:*:*:*:* |
| URL | Tags |
|---|---|
| https://claroty.com/team82/disclosure-dashboard/cve-2023-33364 | Third Party Advisory |
| https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291 | Release Notes Vendor Advisory |